Quest Diagnostics Inc. Share Price Today: Live Updates & Key Insights

Quest Diagnostics Inc. share price today is $195.26, up 0.57%. The stock opened at $194.07 against the previous close of $194.16, with an intraday high of $196.72 and low of $193.52.

Quest Diagnostics Inc. Share Price Chart

Quest Diagnostics Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Quest Diagnostics Inc. Share Price Performance

$195.26 0.0057(0.57%) DGX at 23 Mar 2026 12:42 PM Diagnostics & Research
Lowest Today 193.52
Highest Today 196.72
Today’s Open 194.07
Prev. Close 194.16
52 Week High 213.50
52 Week Low 155.09
Day’s Range: Low 193.52 High 196.72
52-Week Range: Low 155.09 High 213.50
1 day return -
1 Week return -1.78
1 month return -5.79
3 month return +10.81
6 month return +5.76
1 year return +16.75
3 year return +45.46
5 year return +55.12
10 year return -

Quest Diagnostics Inc. Institutional Holdings

Vanguard Group Inc 13.10

BlackRock Inc 9.10

JPMorgan Chase & Co 7.86

T. Rowe Price Associates, Inc. 6.38

State Street Corp 4.75

Boston Partners Global Investors, Inc 3.56

Vanguard Total Stock Mkt Idx Inv 3.18

Geode Capital Management, LLC 2.76

Vanguard 500 Index Investor 2.58

Vanguard Mid Cap Index Institutional 2.19

Morgan Stanley - Brokerage Accounts 2.08

Victory Capital Management Inc. 1.94

Dimensional Fund Advisors, Inc. 1.76

Grantham, Mayo, Van Otterloo & Co., LLC 1.65

Wells Fargo & Co 1.64

Amvescap Plc. 1.54

EdgePoint Investment 1.51

Bank of America Corp 1.49

Davis Selected Advisers 1.45

Victory Sycamore Established Value R 1.33

iShares Core S&P 500 ETF 1.29

Fidelity 500 Index 1.29

NORGES BANK 1.20

State Street® SPDR® S&P 500® ETF 1.19

JPM US Equity Income-Composite 1.13

JPM US Equity Income-MA 1.13

JPMorgan Equity Income I 1.12

T. Rowe Price U.S. Value Equity Tr-D 1.10

FMR Inc 1.09

JHancock Disciplined Value I 1.06

Northern Trust Corp 1.05

T. Rowe Price Dividend Growth 1.04

T. Rowe Price US Dividend Growth Eq Comp 1.04

JPMorgan Mid Cap Value L 1.04

JPM US Mid Cap Value-Composite 1.03

The Goldman Sachs Group Inc 0.97

Vanguard Value Index Inv 0.93

T. Rowe Price US Large-Cap Core Tr-E 0.87

Invesco S&P 500® Equal Weight ETF 0.86

T. Rowe Price US Value Equity Composite 0.84

Quest Diagnostics Inc. Market Status

Strong Buy: 8

Buy: 1

Hold: 10

Sell: 0

Strong Sell: 0

Quest Diagnostics Inc. Fundamentals

Market Cap 21721.18 M

PB Ratio 2.9751

PE Ratio 22.1634

Enterprise Value 27496.64 M

Total Assets 16225.00 M

Volume 2030142

Quest Diagnostics Inc. Company Financials

Annual Revenue FY25:11035000000 11035.0M, FY24:9872000000 9872.0M, FY23:9297000000 9297.0M, FY22:9883000000 9883.0M, FY21:10788000000 10788.0M

Annual Profit FY25:3523000000 3523.0M, FY24:3244000000 3244.0M, FY23:3075000000 3075.0M, FY22:3433000000 3433.0M, FY21:4209000000 4209.0M

Annual Net worth FY25:992000000 992.0M, FY24:871000000 871.0M, FY23:763000000 763.0M, FY22:946000000 946.0M, FY21:1995000000 1995.0M

Quarterly Revenue Q4/2025:2806000000 2806.0M, Q3/2025:2816000000 2816.0M, Q2/2025:2761000000 2761.0M, Q1/2025:2652000000 2652.0M, Q4/2024:2621000000 2621.0M

Quarterly Profit Q4/2025:914000000 914.0M, Q3/2025:949000000 949.0M, Q2/2025:943000000 943.0M, Q1/2025:863000000 863.0M, Q4/2024:858000000 858.0M

Quarterly Net worth Q4/2025:245000000 245.0M, Q3/2025:245000000 245.0M, Q2/2025:282000000 282.0M, Q1/2025:220000000 220.0M, Q4/2024:222000000 222.0M

About Quest Diagnostics Inc. & investment objective

Company Information Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Organisation Diagnostics & Research

Employees 46000

Industry Diagnostics & Research

CEO Mr. James E. Davis

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Quest Diagnostics Inc. FAQs

What is the share price of Quest Diagnostics Inc. today?

The current share price of Quest Diagnostics Inc. is $195.26.

Can I buy Quest Diagnostics Inc. shares in India?

Yes, Indian investors can buy Quest Diagnostics Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Quest Diagnostics Inc. shares in India?

You can easily invest in Quest Diagnostics Inc. shares from India by:

Can I buy fractional shares of Quest Diagnostics Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Quest Diagnostics Inc.?

Quest Diagnostics Inc. has a market cap of $21721.18 M.

In which sector does Quest Diagnostics Inc. belong?

Quest Diagnostics Inc. operates in the Diagnostics & Research sector.

What documents are required to invest in Quest Diagnostics Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Quest Diagnostics Inc.?

The PE ratio of Quest Diagnostics Inc. is 22.16 and the PB ratio is 2.98.